Capital International Investors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,626,644
| Closed | -$25.6M | – | 437 |
|
|
2022
Q1 | $25.6M | Sell |
2,626,644
-5,505,307
| -68% | -$53.7M | 0.01% | 391 |
|
|
2021
Q4 | $116M | Buy |
8,131,951
+1,022,062
| +14% | +$14.6M | 0.02% | 306 |
|
|
2021
Q3 | $142M | Buy |
7,109,889
+215,800
| +3% | +$4.32M | 0.03% | 274 |
|
|
2021
Q2 | $152M | Buy |
6,894,089
+5,097,178
| +284% | +$112M | 0.03% | 266 |
|
|
2021
Q1 | $61M | Buy |
1,796,911
+1,046,911
| +140% | +$35.6M | 0.02% | 327 |
|
|
2020
Q4 | $30.2M | Buy |
+750,000
| New | +$30.2M | 0.01% | 368 |
|